Fig. 6. Immunohistochemically staining for astrogliosis marker (GFAP). Treatment with Apelin-13 in Huntington’s disease (HD) rats significantly reduced astrogliosis (***P<0.001). (A) Nuclei stained by DAPI. (B) Primary antibody to GFAP. (C) Merge.

Anat Cell Biol 2024;57:419~430 https://doi.org/10.5115/acb.23.284

© Anat Cell Biol